Federal Register #FDA-2025-N-0421

FDA Debarment Order: Oscar Bobo Prohibited from Importing Drugs

This notice announces a regulatory enforcement action by the Food and Drug Administration (FDA), not a procurement opportunity. - Government Buyer: - Food and Drug Administration (FDA), Department of Health and Human Services - Action Details: - Final debarment order issued against Oscar Bobo - Prohibits import or offer for import of any drug into the United States for five years - Based on importing misbranded drugs containing tadalafil and sildenafil - Drugs were not properly labeled or registered as required by law - No products or services are being solicited or awarded - Unique Requirements: - This is a regulatory action, not a request for goods or services - No procurement activity is associated with this notice

Description

The Food and Drug Administration (FDA) is issuing a final order debarring Oscar Bobo for 5 years from importing or offering for import any drug into the United States. This action is based on findings that Mr. Bobo engaged in a pattern of importing misbranded drugs in amounts inconsistent with personal use, which were not designated in an authorized electronic data interchange system as FDA-regulated products. Mr. Bobo was notified of the proposed debarment and given an opportunity to request a hearing but failed to respond, waiving his right to a hearing. The debarment is effective May 15, 2026.

View original listing